Commercial-News (Danville, Illinois; June 21) – “My current study tests the feasibility of a standardized protocol for high-flow nasal oxygen therapy (HFNOT),” explains Dr. Reinhart. “This won’t prove definitively that high-flow is needed or better for patients with blastomycosis. Instead, the data we collect will help us design a larger study to examine whether patients benefit from starting HFNOT right away.”
Veterinary Researcher Seeks to Improve Treatment for Fungal Infection of Dogs
